ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Pfizer at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Pfizer takes part in 3 sessions at ESMO 2026 in Madrid, and exhibits at Booth 8031. Its program centres on advanced non-small cell lung cancer, including seven-year trial results in first-line ALK-positive disease that point towards managing it as a chronic condition, and new antibody therapies. It also covers individualised treatment decisions in metastatic breast cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
Global pharmaceutical company whose oncology portfolio spans breast, lung, prostate, bladder and blood cancers, including antibody-drug conjugates from its Seagen acquisition. | Booth Exhibiting at Booth 8031 Satellite Sat Oct 24 13:00–14:30 Satellite Sat Oct 24 18:30–20:00 Pfizer - Breaking the Treatment Plateau in Advanced NSCLC: Antibody Therapy Redefined Lung & thoracic cancers Satellite Sun Oct 25 18:30–20:00 |
Find decision makers at Pfizer
Tell us what you sell and we’ll find the people at Pfizer most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction